Avalon GloboCare Corp. is a clinical-stage biotech company that specializes in immune effector cell therapy, exosome technology, and COVID-19 related diagnostics and therapeutics. Through its subsidiary structure, the company offers strategic advisory and outsourcing services to support clients in the healthcare and CellTech markets. With its unique integration of verticals, Avalon is establishing a leading role in the fields of cellular immunotherapy, exosome technology, and regenerative therapeutics. The company is listed on the NASDAQ and is committed to advancing innovative and transformative bio-developments.